Federal award (BPA CALL, fiscal year 2022)
Recipient: PROGENICS PHARMACEUTICALS INC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2023-06-08 to 2023-06-08
Current total value of award: $46913.36
Description: PILARIFY (PIFLUFOLASTAT F-18) INJECTION